Senators promote cannabis and CBD research

Cannabis is promoted at the Congress

Cannabidiol, also known as CBD, is one of the key components of marijuana. It’s becoming more and more popular nowadays for its most sought after health benefits. It’s currently garnering more attention than THC because of its relatively milder and less intense side effects. CBD is a non-psychoactive component of marijuana, thus, it doesn’t affect mentation and behavior.

Senators Dianne Feinstein, Chuck Grassley, and Brian Schatz are responsible for the new Cannabidiol and Marijuana Research Expansion Act. They moved that marijuana, as well as CBD research, be a priority to further expand scientific research of medical cannabis and boost the support of its legalization. The bill would change marijuana’s definition in the Controlled Substance Act. This would entail that hemp-derived synthetic equivalent of CBD containing no more than 0.3% tetrahydrocannabinol or THC would no longer be considered as marijuana.

The Federal Bill and its Main Provisions

In the said act, the U.S. Food and Drug Administration would play a part in making sure medications that contain or are derived from marijuana are regulated and safe. Because of this, extensive research regarding the medical benefits of marijuana and its derivatives should be made. Moreover, licensed doctors can also discuss CBD or marijuana’s medical advantages and disadvantages as a treatment option for their patients.

The senators have stated parents’ testimonies regarding CBD and marijuana in the treatment of various childhood illnesses such as severe epilepsy, which is very difficult to treat through the means of traditional western medicine. Thus, they have ruled in the potential value of CBD in treating these resistant diseases.

The bill would call for a faster and more streamlined process in reviewing medical marijuana research. This would also mean a more efficient development of medicine derived from CBD and marijuana, through the approval of the FDA. Lastly, the bill requires the Department of Health and Human Services [3] to let the Congress in the know about the potential harmful or beneficial effects of marijuana and marijuana-containing drugs on the human body, brain, and mental faculties.

CBD in the modern setting

The use of CBD in day-to-day lives is increasing among more people every day. One of the most common ways people use CBD is through cannabidiol or CBD oil. Among the most frequent reasons for CBD, oil use is pain, sleeplessness, and anxiety. For most people, it even has a positive impact on their focus and mind clarity during the day. It’s been an ideal companion for most people who are under constant stress. As previously mentioned, parents are also trying to use this as a cure for difficult to treat childhood illnesses such as epilepsy. Because of this, lawmakers have made it a priority to expand scientific and evidence-based knowledge regarding marijuana or CBD’s efficacy and safety in treating a variety of medical conditions that are otherwise refractory to modern medicine.